About Us
The Serbian Group for Primary Immunodeficiencies (SGPI) was established in 2019, initially based in Niš, under the expert leadership of Professor Goran Marjanović from the University Clinical Center Niš. The association was founded with a clear goal: to improve the recognition, diagnosis, and treatment of primary immunodeficiencies (PID) in Serbia.
In August 2024, a new presidency and Board of Directors were elected, with the current headquarters in Belgrade. We launched new development directions and further strengthened SGPI as a national platform for comprehensive action in the field of Inborn Errors of Immunity (IEI), as PID are currently classified.
Today, SGPI brings together an increasing number of active and honorary members and serves as a hub for continuous professional development, knowledge exchange, and the advancement of clinical practice.
The recipients of the 2026 Lilić-Abinun Scholarships are Dr. Marija Simić (Project: Advancing Post-Transplant Care for Children with Inborn Errors of Immunity in Serbia) and Dr. Borko Gobeljić (Project: Pretransplant
We are delighted to share the news that selected abstracts from this year’s SGPI Symposium, held in Belgrade and Novi Sad on 24–25 April 2026, have been published in the
Which AI tools can truly be useful to clinicians and researchers? How can we find relevant publications and high-quality sources more efficiently, while recognizing the limitations and potential pitfalls of